Evaluation of the antigenic relatedness and cross-protective immunity of the neuraminidase between human influenza A (H1N1) virus and highly pathogenic avian influenza A (H5N1) virus

被引:15
|
作者
Lu, Xiuhua [1 ]
Liu, Feng [1 ]
Zeng, Hui [1 ]
Sheu, Tiffany [1 ]
Achenbach, Jenna E. [1 ]
Veguilla, Vic [1 ]
Gubareva, Larisa V. [1 ]
Garten, Rebecca [1 ]
Smith, Catherine [1 ]
Yang, Hua [1 ]
Stevens, James [1 ]
Xu, Xiyan [1 ]
Katz, Jacqueline M. [1 ]
Tumpey, Terrence M. [1 ]
机构
[1] Ctr Dis Control & Prevent, Natl Ctr Immunizat & Resp Dis, Influenza Div, Atlanta, GA 30333 USA
关键词
Influenza virus; Anti-neuraminidase antibodies; Antigenic and genetic analyses; Passive immunization; BALB/c mice; Cross-protective immunity; 3-DIMENSIONAL STRUCTURE; VIRAL NEURAMINIDASE; ANTIBODY-RESPONSES; CRYSTAL-STRUCTURES; LETHAL INFLUENZA; VACCINE; H3N2; HEMAGGLUTININ; INFECTION; SEQUENCE;
D O I
10.1016/j.virol.2014.02.011
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
To determine the genetic and antigenic relatedness as well as the cross-protective immunity of human HI NI and avian H5N1 influenza virus neuraminidase (NA), we immunized rabbits with either a baculovirus-expressed recombinant NA from A/Beijing/262/95 (BJ/262) H1N1 or A/Hong Kong/483/97 (HK/483) H5N1 virus. Cross-reactive antibody responses were evaluated by multiple serological assays and cross-protection against H5N1 virus challenge was evaluated in mice. In a neuraminidase inhibition (NI) test, the antisera exhibited substantial inhibition of NA activity of the homologous virus, but failed to inhibit the NA activity of heterologous virus. However, these antisera exhibited low levels of cross-reactivity measured by plaque size reduction, replication inhibition, single radial hemolysis, and ELISA assays. Passive immunization with HK/483 NA-specific antisera significantly reduced virus replication and disease, and afforded almost complete protection against lethal homologous virus challenge in mice. However, passive immunization with BJ/262 (H1N1) NA-specific antisera was ineffective at providing cross-protection against lethal H5N1 virus challenge and only slightly reduced weight loss. Substantial amino acid variation among the NA antigenic sites was observed between BJ/262 and HK/483 virus, which was consistent with the lack of cross-reactive NI activity by the antibody and limited cross-protective immunity in mice. These results show a strong correlation between the lack of cross-protective immunity and low structural similarities of NA from a human seasonal HI NI virus and an avian H5N1 influenza virus. Published by Elsevier Inc
引用
收藏
页码:169 / 175
页数:7
相关论文
共 50 条
  • [1] Mucosal administration of raccoonpox virus expressing highly pathogenic avian H5N1 influenza neuraminidase is highly protective against H5N1 and seasonal influenza virus challenge
    Kingstad-Bakke, Brock
    Kamlangdee, Attapon
    Osorio, Jorge E.
    VACCINE, 2015, 33 (39) : 5155 - 5162
  • [2] Cross-protective immunity against influenza A/H1N1 virus challenge in mice immunized with recombinant vaccine expressing HA gene of influenza A/H5N1 virus
    Yang, Song
    Niu, Shumeng
    Guo, Zhihua
    Yuan, Ye
    Xue, Kun
    Liu, Sinan
    Jin, Hong
    VIROLOGY JOURNAL, 2013, 10
  • [3] Cross-protective immunity against influenza A/H1N1 virus challenge in mice immunized with recombinant vaccine expressing HA gene of influenza A/H5N1 virus
    Song Yang
    Shumeng Niu
    Zhihua Guo
    Ye Yuan
    Kun Xue
    Sinan Liu
    Hong Jin
    Virology Journal, 10
  • [4] Selection of antigenic variants of an H5N1 highly pathogenic avian influenza virus in vaccinated chickens
    Lam Thanh Nguyen
    Nishi, Tatsuya
    Shichinohe, Shintaro
    Chu, Duc-Huy
    Hiono, Takahiro
    Matsuno, Keita
    Okamatsu, Masatoshi
    Kida, Hiroshi
    Sakoda, Yoshihiro
    VIROLOGY, 2017, 510 : 252 - 261
  • [5] Severity of Pneumonia Due to New H1N1 Influenza Virus in Ferrets Is Intermediate between That Due to Seasonal H1N1 Virus and Highly Pathogenic Avian Influenza H5N1 Virus
    van den Brand, Judith M. A.
    Stittelaar, Koert J.
    van Amerongen, Geert
    Rimmelzwaan, Guus F.
    Simon, James
    de Wit, Emmie
    Munster, Vincent
    Bestebroer, Theo
    Fouchier, Ron A. M.
    Kuiken, Thijs
    Osterhaus, Albert D. M. E.
    JOURNAL OF INFECTIOUS DISEASES, 2010, 201 (07) : 993 - 999
  • [6] The Short Stalk Length of Highly Pathogenic Avian Influenza H5N1 Virus Neuraminidase Limits Transmission of Pandemic H1N1 Virus in Ferrets
    Blumenkrantz, Deena
    Roberts, Kim L.
    Shelton, Holly
    Lycett, Samantha
    Barclay, Wendy S.
    JOURNAL OF VIROLOGY, 2013, 87 (19) : 10539 - 10551
  • [7] Cross-protective efficacies of highly-pathogenic avian influenza H5N1 vaccines against a recent H5N8 virus
    Park, Su-Jin
    Si, Young-Jae
    Kim, Jihye
    Song, Min-Suk
    Kim, Se-mi
    Kim, Eun-Ha
    Kwon, Hyeok-il
    Kim, Young-Il
    Lee, Ok-Jun
    Shin, Ok Sarah
    Kim, Chul-Joong
    Shin, Eui-Cheol
    Choi, Young Ki
    VIROLOGY, 2016, 498 : 36 - 43
  • [8] A VLP Vaccine Induces Broad-Spectrum Cross-Protective Antibody Immunity against H5N1 and H1N1 Subtypes of Influenza A Virus
    Wu, Chia-Ying
    Yeh, Yi-Chun
    Chan, Jia-Tsrong
    Yang, Yu-Chih
    Yang, Ji-Rong
    Liu, Ming-Tsan
    Wu, Ho-Sheng
    Hsiao, Pei-Wen
    PLOS ONE, 2012, 7 (08):
  • [9] Prior infection with an H1N1 swine influenza virus partially protects pigs against a low pathogenic H5N1 avian influenza virus
    Van Reeth, Kristien
    Braeckmans, Debby
    Cox, Eric
    Van Borm, Steven
    van den Berg, Thierry
    Goddeeris, Bruno
    De Vleeschauwer, Annebel
    VACCINE, 2009, 27 (45) : 6330 - 6339
  • [10] Avian Influenza A H5N1 Virus
    Loeffelholz, Michael J.
    CLINICS IN LABORATORY MEDICINE, 2010, 30 (01) : 1 - +